The T-cell architecture of pancreatic ductal adenocarcinoma

被引：0
|
作者：
Sivakumar, Shivan [1 ]
Abu Shah, Enas [1 ]
Ahern, David [1 ]
Mangal, Nagina [1 ]
Reddy, Srikanth [1 ]
Rendek, Aniko [1 ]
Soonawalla, Zahir [1 ]
Silva, Michael [1 ]
Middleton, Mark [1 ]
Dustin, Michael [1 ]
机构：
[1] Univ Oxford, Oxford, England
来源：
CANCER RESEARCH | 2019年 / 79卷 / 24期
关键词：
D O I：
10.1158/1538-7445.PANCA19-B52
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B52
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pancreatic Ductal Adenocarcinoma
    Erickson, Lori A.
    MAYO CLINIC PROCEEDINGS, 2017, 92 (09) : 1461 - 1462
  • [22] Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
    Persky, Julia
    Cruz, Sylvia
    Judge, Sean
    Sholevar, Cyrus
    Gholami, Sepideh
    Bold, Richard
    Karnezis, Anthony
    Matsukuma, Karen
    Darrow, Morgan
    Canter, Robert
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S54 - S54
  • [23] Acinar cell plasticity and development of pancreatic ductal adenocarcinoma
    Peter Storz
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 296 - 304
  • [24] Acinar cell plasticity and development of pancreatic ductal adenocarcinoma
    Storz, Peter
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (05) : 296 - 304
  • [25] Cancer stem cell markers in pancreatic ductal adenocarcinoma
    Aksoy, F.
    Kaya, E.
    Egeli, U.
    Dundar, H. Z.
    Tasar, P.
    Aksoy, S. A.
    Ozen, Y.
    Tunca, B.
    Cecener, G.
    Yerci, O.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Tumor cell intrinsic factors dictate T cell infiltration and therapeutic response in pancreatic ductal adenocarcinoma
    Byrne, Katelyn T.
    Li, Jinyang
    Vonderheide, Robert H.
    Stanger, Ben Z.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Exploring Novel Viro-Immunotherapies Using "Armed" Oncolytic Adenoviruses and Adoptive T-cell Therapy to Target Pancreatic Ductal Adenocarcinoma
    Roach, Brett L.
    Yamamoto, Masato
    MOLECULAR THERAPY, 2023, 31 (04) : 298 - 299
  • [28] Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
    Ge, Yang
    Liu, Heshu
    Zhang, Yuanyuan
    Liu, Jian
    Yan, Rui
    Xiao, Zeru
    Fan, Xiaona
    Huang, Xuying
    An, Guangyu
    TRANSLATIONAL ONCOLOGY, 2022, 17
  • [29] Pseudotime dynamics in pancreatic ductal adenocarcinoma reveal different mechanisms of hindrance in immunity through bifurcation of regulatory and cytotoxic T-cell differentiation
    Jainarayanan, A. K.
    Anand, N. Mouroug
    Arbe-Barnes, E. H.
    Bashford-Rogers, R.
    Abu-Shah, E.
    Dustin, M. L.
    Sivakumar, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1458 - S1459
  • [30] Exploring Novel Viro-Immunotherapies Using "Armed" Oncolytic Adenoviruses and Adoptive T-Cell Therapy to Target Pancreatic Ductal Adenocarcinoma
    Roach, Brett L.
    Yamamoto, Masato
    MOLECULAR THERAPY, 2022, 30 (04) : 322 - 322
12345